Gender & Health
Brazilian proposal at the weekend has raised hopes of a breakthrough in the World Trade Organisation's deadlocked talks on poor ountries' access to essential medicines.
Federal prosecutors yesterday charged W.R. Grace & Co. with exposing mine workers and residents in a small mountain community in Montana to deadly asbestos and covering up the danger.
A federal judge on Tuesday ordered the destruction of plantings of genetically modified sugar beets developed by Monsanto Co after ruling previously the U.S. Agriculture Department illegally approved the biotech crop.
A bauxite mine and a proposed refinery in northern Queensland, Australia, to be developed by a Chinese mineral company, has divided local and traditional landowners. Part of a major industrialization scheme, it has also sparked worries among environmentalists.
DuPont and other companies use those synthetic compounds to make an extraordinarily wide range of products, including nonstick cookware (e.g, Teflon), grease-resistant food packaging (e.g., microwave popcorn and pizza boxes), stain-resistant fabrics and carpets (e.g., Stainmaster), shampoos, conditioners, cleaning products, electronic components, paints, firefighting foams, and a host of other artifacts of modern life.
Jurors in a state court in Houston decided yesterday that Johnson & Johnson, the consumer health care company, must pay $772,500 to the family of a Texas woman who died after a patch intended to release pain-killing drugs leaked.
In Eastern India's Jharkand State, tensions are mounting between indigenous tribal communities and the Uranium Corporation of India Limited, or UCIL. Heavy security at a May public hearing on UCIL's planned expansion in the Jagoda region prevented many local activists and villagers from entering. But outside the hearing, activists from the Jharkhandi Organization Against Radiation (JOAR) argued their case for protecting their health and the environment from the horrific impacts of radioactive contaminated waste resulting from uranium mining.
Michaela, a deceased 5 month old, is one of more than 13,000 Argentine children to participate in a clinical study implemented a little more than a year ago by the London-based GlaxoSmithKline, the world's second-largest drug manufacturer.
When individuals sue major corporations, the odds are stacked against them. One woman's fight against an insurance giant details those odds and what it takes to beat them.